A carregar...
Tumor-targeted 4-1BB agonists for combination with T cell bispecific antibodies as off-the-shelf therapy
Endogenous costimulatory molecules on T cells such as 4-1BB (CD137) can be leveraged for cancer immunotherapy. Systemic administration of agonistic anti–4-1BB antibodies, although effective preclinically, has not advanced to phase 3 trials because they have been hampered by both dependency on Fcγ re...
Na minha lista:
| Publicado no: | Sci Transl Med |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7181714/ https://ncbi.nlm.nih.gov/pubmed/31189721 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1126/scitranslmed.aav5989 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|